Clinical and financial impact of pharmacist interventions during patient rounds in intensive care units

Completed

• Conditions: Intensive care; Not Applicable

• Registration Number: ISRCTN39231922
• Lead Sponsor: Erasmus Medical Centre

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2016-10-21
• Last Update Posted: 9 October 2017

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 334

Inclusion Criteria

1. Patients aged at least 18
2. Staying in the ICU during the patient round in which the pharmacist participates

Exclusion Criteria

Participants not fulfilling inclusion criteria

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The proportion of pharmacist recommendation interventions on prescribing that were accepted and implemented by the prescriber. <br><br>Calculated via the number of recommendation interventions that lead to an actual change in prescribing (nominator) divided by the total number of the recommendation interventions made by the pharmacist (denominator). i.e. if the pharmacist intervened on the prescription by recommending that the doctor stop the drug, and the doctor followed the recommendation and actually stopped the prescription, than the intervention was scored as being accepted by the doctor. This outcome was real time/immediately measured. After the patient round, the prescribing system was checked on actual changes in prescribing. After data collection a cross check was done to verify all collected data.